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Introduction
Obesity is an epidemic problem in most industrialized
countries and is also a growing public health problem
in Taiwan with nearly one quarter of the adult popula-
tion currently overweight or obese1. The prevalence of
overweight and obese individuals is particularly high
in the elderly. In Taiwan, 48.3% of men and 57.2% of
women aged 60–69 years are either overweight or
obese (defined as body mass index [BMI] ≥ 24 kg/m2)2.
Obesity is associated with diverse health risks, such as
increased incidence of diabetes mellitus and coronary
heart disease, and mortality of cardiovascular diseases
(CVD)3,4. However, the role of body weight as a risk 
factor for death remains controversial.
Being overweight or obese was positively associ-
ated with an increased risk of all-cause mortality in
the Cancer Prevention Study II5. The rate of death was
lowest among men with a BMI of 23.5–24.9 and among
women with a BMI of 22.0–23.4. However, in the
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SUMMARY
Background: Obesity is associated with diverse health risks, but its role as a risk factor for death remains con-
troversial in the elderly. This study estimated the association of body mass index (BMI) with the risk of death
from any cause and from specific diseases in elderly Taiwanese.
Methods: The Six-Community Hypertension Intervention Project Study, a nationwide population-based cohort,
was conducted in 1982 and followed up for 23 years. Cause of death was ascertained by review of death certifi-
cate files. Proportional hazards models were used to evaluate the association between the baseline BMI and
risk of death.
Results: Of 1,568 participants aged 65 years (range, 60–75 years) at study entry, 1,085 (69%) died during 
follow-up. The relationship between death from any cause and BMI follows a J-shaped pattern. Increasing BMI
categories were associated with increased risk of all-cause mortality (BMI, 25–26.9: hazard ratio, HR, 1.36; 95%
confidence interval, CI, 1.11–1.67; BMI ≥ 27: HR, 1.46; 95% CI, 1.15–1.85). Death from diabetes, cardiovascular
diseases or cancer increased progressively with increasing categories of BMI, and HRs were significantly increased
at BMI levels > 23.0 kg/m2 (BMI, 23–24.9: HR, 1.29; 95% CI, 1.05–1.60; BMI, 25–26.9: HR, 1.58; 95% CI, 1.21–2.05;
BMI ≥ 27: HR, 1.74; 95% CI, 1.29–2.35). These associations were more obvious in men than in women.
Conclusion: This study found that BMI > 25 kg/m2 was a significant independent predictor of all-cause mortal-
ity, especially among older men. BMI > 23 kg/m2 also increased risk of mortality from cancer, cardiovascular
diseases and diabetes. The relationship was J-shaped in older Taiwanese. [International Journal of Gerontology
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National Health and Nutrition Examination Survey I, II
or III, being overweight was not related to increased
mortality6.
The effects of an increasing BMI on mortality risk
are less pronounced in the elderly than in young and
middle-aged adults7–13. Some studies found a greater
BMI to be a risk factor for mortality, while others found
different results. Of the 13 studies of individuals aged
65 years or older reviewed by Heiat et al.14 in 2001,
most showed a non-significant or even a negative asso-
ciation between BMI and all-cause mortality. In 2006,
Janssen et al.15 published a literature review of 26 stud-
ies examining the BMI–mortality relationship in the
elderly. The findings of this meta-analysis showed that
a BMI in the overweight range is not associated with 
a significantly increased risk of mortality, while a BMI
in the obese range is only associated with a modest
increase (about 10%) in mortality risk15.
Data are limited on the relationship between obe-
sity and survival in the Taiwanese population. The aim
of the present study was to examine the association of
BMI with the risk of death from any cause and from
specific diseases in the elderly in Taiwan.
Materials and Methods
Details of the Six-Community Hypertension Interven-
tion Project (SCHIP) Study baseline cohort have been
described previously16. This nationwide study was
conducted in 1982 and followed up for 23 years. The
initiated SCHIP data were collected in six communities
in Taiwan from October 1982 to September 1983. A
total of 7,763 subjects, representative of the general
adult population in Taiwan through stratified system-
atic clustering sampling, participated in a nationwide
population-based survey. All subjects gave written in-
formed consent for participation. Subjects were excluded
if they were aged less than 60 years or older than 75
years, and if they had suffered stroke and were bed-
ridden. To minimize the effect of existing medical con-
ditions on the baseline BMI, we excluded subjects who
died during the first 3 years of follow-up. The remaining
1,568 subjects were included in the analyses.
Data collection
Data on sociodemographic characteristics including sex,
age, exercise habits, smoking habits, alcohol consump-
tion, family history of cardiovascular-related diseases,
physician-diagnosed diseases and medication history
were collected by trained public health workers during
a home visit. During the visit, sitting blood pressure (BP),
weight and height measurements were taken. BMI was
calculated as: body weight (kg)/height (m)2.
Survival status and cause of death through December
31, 2006, was ascertained by review of death certificate
files (documented underlying cause of death by the
International Classification of Diseases, Ninth Revision
[ICD-9], from the Department of Health in Taiwan) 
by a unique subject’s national identification number.
A death was ascribed to CVD if the primary cause of
death was CVD (ICD-9 codes 390–459). Cancer is defined
as ICD-9 codes 140–239. Diabetes is defined as ICD-9
code 250. Death from bronchial or lung diseases is
defined as ICD-9 codes 460–519.
Statistical analysis
Data were analyzed using SAS version 9 (SAS Institute
Inc., Cary, NC, USA). These cutoffs of BMI values corre-
sponded to the definition of overweight and obesity
suggested by the 2000 World Health Organization Asian
Pacific Guideline17. Subjects were classified into under-
weight (BMI < 18.5 kg/m2), normal weight (BMI, 18.5–
22.9), overweight (BMI, 23–24.9), and obese (BMI ≥ 25)
at baseline. We divided the obesity group into two
groups (BMI, 25–26.9, and BMI ≥ 27) to match the def-
inition of obesity (BMI ≥ 27) suggested by the Depart-
ment of Health in Taiwan.
Cox’s proportional hazards models were used to eval-
uate the association between the baseline BMI and
risk of death by adjusting for age, exercise habits, edu-
cation level, alcohol drinking, and smoking status. Study
subjects with normal BMI scores served as controls.
The criteria for statistical significance were p < 0.05 and




The mean age of the study cohort participants was
65.7 ± 4.0 years; 55.3% were men, 36.3% had a history
of hypertension, and 17.5% had a history of diabetes.
The characteristics of the study sample are summa-
rized in Table 1. Overall mean BMI was 22.2±3.3 kg/m2
(21.8±3.0kg/m2 in men and 22.7±3.6kg/m2 in women).
The distribution of the study population categorized
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according to the 2000 World Health Organization Asian
Pacific Guideline is as follows: 11.6% were under-
weight (BMI < 18.5 kg/m2), 54.3% were normal weight
(BMI, 18.5–22.9 kg/m2), 17.5% were overweight (BMI,
23–24.9 kg/m2), and 16.5% were obese (BMI > 25.0 kg/
m2). Based on the categories of classification of the
Department of Health in Taiwan, 6.6% of the cohort
were obese.
Men had significantly higher rates of smoking and
alcohol consumption than women. Men also had sig-
nificantly higher levels of diastolic blood pressure than
women, but lower BMI, fasting blood glucose and
triglyceride levels.
BMI and mortality
Of the 1,568 participants aged 65 years (on average) at
study entry (1982–83), 1,085 (69%) died during the 23
years of follow-up (Table 2). The rates of death from
cancer in men were greater than in women (24.1% vs.
16.6%), but the rates of death from CVD in men were
lower than in women (25.3% vs. 33.3%).
There were more deaths from all causes, cancer,
diabetes and CVD in the higher BMI categories com-
pared with the normal BMI classification. Excessive risk
of death from cancer or lung diseases also was present
in the underweight group. The all-cause mortality (48.1
per 1,000 person-years) was significantly increased at
BMI levels > 25.0 kg/m2 (Figure). Elevated BMI scores
were associated with increased risks of all-cause mor-
tality in adjusted analyses (BMI, 25–26.9: HR, 1.36;
95% CI, 1.11–1.67; BMI ≥ 27: HR, 1.46; 95% CI, 1.15–
1.85). Deaths from diabetes, CVD or cancer increased
progressively with increasing categories of baseline
BMI, and HRs were significantly increased at BMI levels
>23.0 kg/m2 (BMI, 23–24.9: HR, 1.29; 95% CI, 1.05–1.60;
BMI, 25–26.9: HR, 1.58; 95% CI, 1.21–2.05; BMI ≥ 27:
HR, 1.74; 95% CI, 1.29–2.35).
Sex differences
The risk for all causes of death was not significantly
different between women with BMI of 18.5–22.9 and
those with BMI of 23–24.9 or > 25 (Table 3). There was
also no difference in risk of cancer mortality in the over-
weight and obese groups compared with the normal-
weight group in women.
However, the multivariate-adjusted HRs of all causes
of death for the overweight group and obesity group
in men were 1.49 (95% CI, 1.14–1.96) and 1.59 (95% CI,
1.13–2.23), respectively (Table 4). The risk of death from
diabetes, CVD or cancer in men increased progressively
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Table 1. Baseline characteristics of this study’s population*
Characteristics Total subjects Men Women p
(n=1,568) (n=868) (n=700)
Age (yr) 65.7 ± 4.0 65.7 ± 4.0 65.6 ± 4.0 0.421
Educational level (yr)
None 903 (57.6) 337 (38.8) 566 (80.9) < 0.0001
1–6 500 (31.9) 389 (44.8) 111 (15.9)
> 6 165 (10.5) 142 (16.4) 23 (3.3)
Smoking status 561 (35.8) 523 (60.3) 38 (5.4) < 0.0001
Alcohol consumption 244 (15.6) 211 (24.3) 33 (4.7) < 0.0001
Exercise† 986 (70.6) 584 (74.4) 402 (65.8) 0.0005
(n=1,396) (n=785) (n=611)
Hypertension history 569 (36.3) 325 (37.4) 243 (34.7) 0.2868
Diabetes history 17.5 13.5 22.7 0.0011
Body mass index (kg/m2) 22.2 ± 3.3 21.8 ± 3.0 22.7 ± 3.6 < 0.0001
Systolic blood pressure (mmHg) 131.7 ± 22.8 131 ± 22.5 132.5 ± 23.1 0.2127
Diastolic blood pressure (mmHg) 79.5 ± 12.7 80.2 ± 12.8 78.7 ± 12.5 0.0275
Fasting plasma glucose (mg/dL) 100.9 ± 48.3 94.4 ± 35.6 109.3 ± 60.1 < 0.0001
Total cholesterol (mg/dL) 242.4 ± 62.0 239.3 ± 61.0 246.5 ± 63.1 0.1105
Triglyceride (mg/dL) 173.1 ± 70.4 168.2 ± 63.4 179.6 ± 78.2 0.0302
*Data presented as mean ± standard deviation or n (%); †for subjects with complete exercise information.
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Table 2. Relationship of body mass index categories to all-cause and specific disease mortality in overall subjects
Body mass index categories (kg/m2)
< 18.5 18.5–22.9 23–24.9 25–26.9 ≥ 27 
(n = 182) (n = 852) (n = 275) (n = 155) (n = 104)
Death, n (%) 132 (72.5) 574 (67.4) 188 (68.4) 112 (72.3) 79 (76.0)
Follow-up time (person-years) 2,745.9 13,858.9 4,450.6 2,327.2 1,563.2
Cumulative mortality rate 48.1 41.4 42.2 48.1 50.5
(per 1,000 person-years)
HR (95% CI)*
All-cause mortality 1.18 (0.98–1.43) 1 [Reference] 1.09 (0.92–1.28) 1.36 (1.11–1.67) 1.46 (1.15–1.85)
Coronary heart disease mortality 1.87 (0.91–3.86) 1 [Reference] 1.44 (0.73–2.84) 0.73 (0.22–2.41) 0.41 (0.05–2.96)
(codes 410–414)†
Stroke mortality (codes 430–438)† 0.40 (0.17–0.93) 1 [Reference] 1.41 (0.94–2.11) 1.52 (0.91–2.55) 1.50 (0.81–2.77)
Diabetes mortality (code 250)† 0.59 (0.18–1.93) 1 [Reference] 1.53 (0.79–2.98) 2.90 (1.45–5.77) 3.26 (1.52–6.99)
Cancer mortality (codes 140–208)† 1.86 (1.29–2.67) 1 [Reference] 1.11 (0.76–1.61) 1.61 (1.04–2.50) 1.89 (1.15–3.13)
Respiratory mortality  2.04 (1.40–2.98) 1 [Reference] 0.60 (0.36–1.01) 0.76 (0.40–1.46) 0.71 (0.31–1.62)
(codes 460–519)†
Heart diseases (codes 401–429)† 0.77 (0.42–1.39) 1 [Reference] 0.81 (0.54–1.21) 0.88 (0.47–1.64) 1.05 (0.53–2.08)
CVD mortality (codes 390–459)† 0.69 (0.44–1.08) 1 [Reference] 1.37 (1.04–1.82) 1.33 (0.91–1.94) 1.39 (0.90–2.16)
Diabetes and CVD mortality 0.58 (0.45–1.03) 1 [Reference] 1.39 (1.08–1.91) 1.55 (1.12–2.15) 1.66 (1.14–2.43)
Diabetes, CVD and cancer 1.11 (0.85–1.45) 1 [Reference] 1.29 (1.05–1.60) 1.58 (1.21–2.05) 1.74 (1.29–2.35)
mortality
*Cox regression model: adjusted for age, sex, alcohol intake status, smoking status, education levels and exercise; †death certificates 






































































































































Body mass index categories
< 18.5 18.5–22.9 23–24.9 25–26.9≥ 27< 18.5 18.5–22.9 23–24.9 25–26.9
Figure. Relationship of categories of body mass index to cumulative all-cause mortality and specific cause mortality in men
and women.
with scores of baseline BMI > 23.0 kg/m2, and HRs were
significantly increased (BMI, 23–24.9: HR, 1.39; 95% CI,
1.05–1.85; BMI ≥ 27: HR, 1.83; 95% CI, 1.29–2.60; BMI,
25–26.9: HR, 2.02; 95% CI, 1.30–3.12).
Discussion
In this nationwide cohort of the elderly, the average
baseline BMI was 22.2 kg/m2 and BMI was a significant
independent predictor of all-cause, cancer, CVD and
diabetes mortality. A BMI > 25 kg/m2 was associated
with an increased risk of all-cause mortality, and a BMI
> 23 kg/m2 also increased the risk of mortality from
cancer, CVD and diabetes. However, these associations
were more obvious in men than in women. Our study
showed that the relationship between death from any
cause and BMI follows a J-shaped pattern in elderly
men and women.
Obesity and overweight combined is the second
leading cause of preventable death18. Previous studies
have demonstrated a strong association between obesity
and decreased survival in the general population, pri-
marily because of the increased risk of CVD3,19. A BMI
> 30 kg/m2 was associated with an increased risk of all-
cause mortality in a cohort study of 7,735 middle aged
men19 and with a significantly increased risk of death
from CVD in the Nurses’ Health Study3.
In contrast to the general population, the role of
increased BMI as a risk factor for death remains con-
troversial in elderly subjects. Kulminski et al.20 reported
in their 9-year follow-up study of older Americans that
the mortality risk pattern was higher for lower BMI
(< 22.0) and flat for higher BMI. Overweight or obesity
scores (BMI, 25.0–34.9) were not risk factors for all-
cause mortality. The relationship between BMI and
mortality exhibited an inverse J shape. Corrada et al.21
also showed similar relationships in a California co-
hort study. Being overweight (relative risk, 1.01) was
not associated with excess mortality, but obese partic-
ipants (relative risk, 1.25) had significantly increased
mortality.
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Table 3. Relationship of categories of body mass index to all-cause and specific disease mortality in women
Body mass index categories (kg/m2)
< 18.5 18.5–22.9 23–24.9 25–26.9 ≥ 27 
(n = 72) (n = 360) (n = 131) (n = 77) (n = 60)
Death, n (%) 49 (68.1) 220 (61.1) 85 (64.9) 51 (66.2) 42 (70.0)
Follow-up time (person-years) 1,147.2 6,012.9 2,241.3 1,237.4 973.4
Cumulative mortality rate 42.7 36.6 37.9 41.2 43.1
(per 1,000 person-years)
HR (95% CI)*
All-cause mortality 1.23 (0.89–1.67) 1 [Reference] 1.04 (0.81–1.24) 1.21 (0.89–1.64) 1.34 (0.96–1.87)
Coronary heart disease mortality 2.43 (0.71–8.34) 1 [Reference] 3.10 (1.19–8.06) 0.68 (0.08–5.49) –
(codes 410–414)†
Stroke mortality (codes 430–438)† 0.66 (0.23–1.88) 1 [Reference] 1.30 (0.72–2.37) 1.39 (0.67–2.92) 1.78 (0.85–3.73)
Diabetes mortality (code 250)† 0.36 (0.05–2.71) 1 [Reference] 1.70 (0.77–3.75) 2.54 (1.07–6.02) 0.90 (0.21–3.93)
Cancer mortality (codes 140–208)† 2.33 (1.27–4.28) 1 [Reference] 0.72 (0.34–1.50) 0.91 (0.38–2.18) 1.93 (0.95–3.94)
Respiratory mortality  2.22 (1.24–4.33) 1 [Reference] 0.49 (0.21–1.17) 0.48 (0.15–1.57) 0.98 (0.34–2.78)
(codes 460–519)†
Heart diseases (codes 401–429)† 0.55 (0.20–1.52) 1 [Reference] 0.87 (0.49–1.53) 0.90 (0.39–2.08) 0.89 (0.35–2.28)
CVD mortality (codes 390–459)† 0.67 (0.33–1.35) 1 [Reference] 1.33 (0.89–1.99) 1.23 (0.72–2.09) 1.42 (0.81–2.50)
Diabetes and CVD mortality 0.61 (0.32–1.18) 1 [Reference] 1.36 (0.95–1.95) 1.44 (0.92–2.25) 1.31 (0.78–2.21)
Diabetes, CVD and cancer 1.13 (0.74–1.73) 1 [Reference] 1.18 (0.86–1.63) 1.30 (0.87–1.93) 1.48 (0.98–2.26)
mortality
*Cox regression model: adjusted for age, sex, alcohol intake status, smoking status, education levels and exercise; †death certificates 
using the National Death Files (International Classification of Diseases, Ninth Revision). HR = hazard ratio; CI = confidence interval; CVD =
cardiovascular disease.
The literature review in an elderly population sur-
vey by Janssen et al.15 showed that the summary rela-
tive risk of all-cause mortality for a BMI of 25–29.9 was
1.00 and that for a BMI within the obese range was
1.10 (95% CI, 1.06–1.13). According to selective survival
hypothesis, individuals susceptible to the risky effects
of an elevated BMI may have already died before get-
ting old. With increasing age, subjects are progressively
more strongly selected survivors. Thus, if we select an
elderly group to evaluate BMI effect, the results tend
to be neutral because they are resistant to the effects of
a high BMI. Our findings did not support this conten-
tion as the HRs of all-cause mortality were significant
for a BMI > 25. This study showed that the relationship
between BMI and mortality in the elderly was not 
different from that in the general population. The dif-
ference in results between our study and the study 
of Janssen et al.15 may be explained by differences in
average BMI scores between cohorts. Asians obviously
have lower BMI values and lower CVD mortality than
Western populations. The adverse effects of high BMI
on mortality might be postponed and last into the
geriatric phase of life.
In previous studies of older Chinese and Japanese
people22,23, BMI was apparently inversely related to
all-cause mortality after a short-term follow-up (e.g., 
4 years). In those with multiple comorbidities, obesity
was associated with better outcomes, whereas in those
with initially good health status, obesity was associ-
ated with worsened outcomes. To minimize the effect
of existing medical comorbidities on the BMI in our
study, subjects who died during the first 3 years of
follow-up were excluded. Therefore, long-term effects
of a high BMI were positively associated with all-cause
mortality.
Our study confirms the findings of previous studies
demonstrating that the relationship between all-cause
mortality and BMI categories follows a J-shaped pat-
tern24,25. In the Korean Cancer Prevention Study, the 
J-shaped risk relationship has been documented;
however, the relative risk associated with BMI declined
in the elderly. Loss of J-shaped pattern was noticed in
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Table 4. Relationship of categories of body mass index to all-cause and specific disease mortality in men
Body mass index categories (kg/m2)
< 18.5 18.5–22.9 23–24.9 25–26.9 ≥ 27 
(n = 110) (n = 492) (n = 144) (n = 78) (n = 44)
Death, n (%) 83 (75.5) 354 (72.0) 103 (71.5) 61 (78.2) 37 (84.1)
Follow-up time (person-years) 1,598.8 7,845.9 2,209.4 1,089.7 589.8
Cumulative mortality rate 51.9 45.1 46.6 55.9 62.7
(per 1,000 person-years)
HR (95% CI)*
All-cause mortality 1.14 (0.90–1.45) 1 [Reference] 1.13 (0.91–1.41) 1.49 (1.14–1.96) 1.59 (1.13–2.23)
Coronary heart disease mortality 
(codes 410–414)† 1.51 (0.61–3.77) 1 [Reference] 0.57 (0.17–1.95) 0.87 (0.20–3.76) 0.73 (0.10–5.47)
Stroke mortality (codes 430–438)† 0.22 (0.05–0.92) 1 [Reference] 1.54 (0.89–2.69) 1.65 (0.80–3.42) 1.03 (0.32–3.33)
Diabetes mortality (code 250)† 0.96 (0.21–4.34) 1 [Reference] 1.18 (0.31–4.04) 3.34 (1.04–10.68) 12.15 (4.59–32.16)
Cancer mortality (codes 140–208)† 1.60 (1.01–2.54) 1 [Reference] 1.31 (0.84–2.05) 2.81 (1.26–3.47) 1.68 (0.81–3.49)
Respiratory mortality 
(codes 460–519)† 2.00 (1.27–3.16) 1 [Reference] 0.70 (0.37–1.33) 1.00 (0.45–2.18) 0.48 (0.12–1.97)
Heart diseases (codes 401–429)† 0.86 (0.40–1.86) 1 [Reference] 0.77 (0.44–1.36) 0.83 (0.33–2.12) 1.18 (0.43–3.23)
CVD mortality (codes 390–459)† 0.72 (0.40–1.28) 1 [Reference] 1.45 (0.98–2.14) 1.33 (0.78–2.31) 1.28 (0.62–2.65)
Diabetes and CVD mortality 0.72 (0.42–1.25) 1 [Reference] 1.43 (0.98–2.08) 1.64 (1.01–2.67) 2.24 (1.30–3.87)
Diabetes, CVD and cancer 1.86 (0.77–1.54) 1 [Reference] 1.39 (1.05–1.85) 1.83 (1.29–2.60) 2.02 (1.30–3.12)
mortality
*Cox regression model: adjusted for age, sex, alcohol intake status, smoking status, education levels and exercise; †death certificates 
using the National Death Files (International Classification of Diseases, Ninth Revision). HR = hazard ratio; CI = confidence interval; CVD =
cardiovascular disease.
the group above the age of 64 years. In our study,
those with a low BMI had higher risk from respiratory
death, whereas those with a high BMI had higher risk
from cancer, diabetes and CVD. The J-shaped risk rela-
tionship has still remained in this older Taiwanese
population.
Higher BMIs are most likely to contribute to the risk
associated with CVD in Western countries. Since the dis-
tribution of major causes of death may differ between
Taiwanese and inhabitants of Western countries, obesity
is likely to contribute to the risk of death from cancer
and diabetes in this 23-year prospective study.
Progressive increases in risks associated with BMI
were seen in both sexes; however, HRs for all-cause
mortality were significant only among men. Low BMI
(< 18.5) was associated with higher mortality of cancer
and respiratory disease in both sexes. Some studies
have also found differences in the BMI–mortality asso-
ciation for men and women26,27.
Limitation
When interpreting our results regarding baseline BMI
scores, it is important to note that we were unable to
evaluate weight changes, body fat or fat distribution
during the follow-up period. We assumed that the influ-
ence of being overweight or obese defined by BMI on
the risk of death is, in part, reflected by the increased
body fat mass in those with an elevated BMI. However,
the relationship between BMI with body fatness is
weaker in the elderly compared with younger adults28.
Furthermore, in a study by Heitmann et al.29, greater
body fat quintile was a risk for mortality in a group 
of 60-year-old Swedish men. The effect of a high BMI
on mortality might be underestimated in older men
and women. Limitations include a single baseline mea-
surement of BMI to predict events several years in 
the future.
Conclusion
The purpose of this study was to determine the effect
of an elevated BMI on mortality risk from any cause
and major causes in men and women aged 60 years
and older. The result showed that BMI is an indepen-
dent risk factor for all causes, cancer, diabetes or CVD
mortality in this cohort. It is clear that a BMI in the
obesity range is associated with a significantly increased
risk of all-cause mortality in the elderly, and a BMI in
the overweight range is associated with a significantly
increased risk of mortality from cancer, diabetes and
CVD in elderly Taiwanese. These findings need to be
confirmed by additional studies.
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